374 related articles for article (PubMed ID: 10694044)
41. Neuroprotective actions of flavones and flavonols: mechanisms and relationship to flavonoid structural features.
Dajas F; Andrés AC; Florencia A; Carolina E; Felicia RM
Cent Nerv Syst Agents Med Chem; 2013 Mar; 13(1):30-5. PubMed ID: 23092407
[TBL] [Abstract][Full Text] [Related]
42. Intake of flavonols and flavones and risk of coronary heart disease in male smokers.
Hirvonen T; Pietinen P; Virtanen M; Ovaskainen ML; Häkkinen S; Albanes D; Virtamo J
Epidemiology; 2001 Jan; 12(1):62-7. PubMed ID: 11138821
[TBL] [Abstract][Full Text] [Related]
43. Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with alpha-linolenic acid.
Sugihara N; Arakawa T; Ohnishi M; Furuno K
Free Radic Biol Med; 1999 Dec; 27(11-12):1313-23. PubMed ID: 10641726
[TBL] [Abstract][Full Text] [Related]
44. Dietary Flavonoids and Cardiovascular Disease: A Comprehensive Dose-Response Meta-Analysis.
Micek A; Godos J; Del Rio D; Galvano F; Grosso G
Mol Nutr Food Res; 2021 Mar; 65(6):e2001019. PubMed ID: 33559970
[TBL] [Abstract][Full Text] [Related]
45. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines.
Kuntz S; Wenzel U; Daniel H
Eur J Nutr; 1999 Jun; 38(3):133-42. PubMed ID: 10443335
[TBL] [Abstract][Full Text] [Related]
46. The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens.
Wiseman H
Proc Nutr Soc; 1999 Feb; 58(1):139-46. PubMed ID: 10343351
[TBL] [Abstract][Full Text] [Related]
47. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants.
Miean KH; Mohamed S
J Agric Food Chem; 2001 Jun; 49(6):3106-12. PubMed ID: 11410016
[TBL] [Abstract][Full Text] [Related]
48. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships.
Chen CC; Chow MP; Huang WC; Lin YC; Chang YJ
Mol Pharmacol; 2004 Sep; 66(3):683-93. PubMed ID: 15322261
[TBL] [Abstract][Full Text] [Related]
49. The Impact of Dietary Flavonols on Central Obesity Parameters in Polish Adults.
Popiolek-Kalisz J
Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501081
[TBL] [Abstract][Full Text] [Related]
50. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals.
Rimm EB; Katan MB; Ascherio A; Stampfer MJ; Willett WC
Ann Intern Med; 1996 Sep; 125(5):384-9. PubMed ID: 8702089
[TBL] [Abstract][Full Text] [Related]
51. Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria.
Kubo I; Kinst-Hori I; Chaudhuri SK; Kubo Y; Sánchez Y; Ogura T
Bioorg Med Chem; 2000 Jul; 8(7):1749-55. PubMed ID: 10976523
[TBL] [Abstract][Full Text] [Related]
52. Dietary intakes of flavonols and flavones and coronary heart disease in US women.
Lin J; Rexrode KM; Hu F; Albert CM; Chae CU; Rimm EB; Stampfer MJ; Manson JE
Am J Epidemiol; 2007 Jun; 165(11):1305-13. PubMed ID: 17379619
[TBL] [Abstract][Full Text] [Related]
53. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA.
Lean ME; Noroozi M; Kelly I; Burns J; Talwar D; Sattar N; Crozier A
Diabetes; 1999 Jan; 48(1):176-81. PubMed ID: 9892240
[TBL] [Abstract][Full Text] [Related]
54. Interactions affecting the bioavailability of dietary polyphenols in vivo.
Scholz S; Williamson G
Int J Vitam Nutr Res; 2007 May; 77(3):224-35. PubMed ID: 18214024
[TBL] [Abstract][Full Text] [Related]
55. Respective bioavailability of quercetin aglycone and its glycosides in a rat model.
Morand C; Manach C; Crespy V; Remesy C
Biofactors; 2000; 12(1-4):169-74. PubMed ID: 11216481
[TBL] [Abstract][Full Text] [Related]
56. [Pharmacological activities of myricetin and its glycosides].
Xu C; Liu YL; Gao ZW; Jiang HM; Xu CJ; Li X
Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(15):3575-3583. PubMed ID: 32893546
[TBL] [Abstract][Full Text] [Related]
57. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN Study.
Tabak C; Arts IC; Smit HA; Heederik D; Kromhout D
Am J Respir Crit Care Med; 2001 Jul; 164(1):61-4. PubMed ID: 11435239
[TBL] [Abstract][Full Text] [Related]
58. Relaxation to flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure-activity relationships.
Chan EC; Pannangpetch P; Woodman OL
J Cardiovasc Pharmacol; 2000 Feb; 35(2):326-33. PubMed ID: 10672869
[TBL] [Abstract][Full Text] [Related]
59. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study.
Janssen K; Mensink RP; Cox FJ; Harryvan JL; Hovenier R; Hollman PC; Katan MB
Am J Clin Nutr; 1998 Feb; 67(2):255-62. PubMed ID: 9459373
[TBL] [Abstract][Full Text] [Related]
60. The relationship between fasting plasma concentrations of selected flavonoids and their ordinary dietary intake.
Cao J; Zhang Y; Chen W; Zhao X
Br J Nutr; 2010 Jan; 103(2):249-55. PubMed ID: 19747418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
